Kiniksa Pharmaceuticals Ltd (KNSA) Price Prediction & ForecastKNSAKiniksa Pharmaceuticals Ltd

Alphio's KNSA stock price prediction model matches the current Kiniksa Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $78.68 (+0.11%). The 1-week path is $76.58 (-2.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kiniksa Pharmaceuticals Ltd (KNSA) is a good buy right now due to its current price of $78.59, which is below the average analyst price target of $90. Additionally, the company's gross margin has improved to 90.32% in Q2 2026, and it reported a significant year-over-year revenue growth of 55% to $243.6 million. The main risk is its high forward P/E ratio of 59.52, indicating that the stock may be overvalued if growth slows.

Kiniksa Pharmaceuticals Ltd (KNSA) last closed at $78.59, losing -1.69%. These facts feed the 1-day and 1-week KNSA price prediction above.